Cargando…

Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

Our objective was to study nonalcoholic fatty liver disease (NAFLD) as a relevant risk factor associated with hepatocellular carcinoma (HCC) in patients with and without cirrhosis. HCC is a common cancer worldwide that predominantly involves patients with hepatic cirrhosis. HCC has recently been lin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inayat, Faisal, Ur Rahman, Zia, Hurairah, Abu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2016
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045331/ https://www.ncbi.nlm.nih.gov/pubmed/27733959 http://dx.doi.org/10.7759/cureus.754

Ejemplares similares

Enigma of Extrapulmonary Tuberculosis: Where Do We Stand?
por: Inayat, Faisal, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
por: Kikuchi, Luciana, et al.
Publicado: (2014)

The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania
por: Valantinas, Jonas, et al.
Publicado: (2012)

A Prediction Model of the Incidence of Nonalcoholic Fatty Liver Disease With Visceral Fatty Obesity: A General Population-Based Study
por: Zhou, Yang, et al.
Publicado: (2022)

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Sumida, Yoshio, et al.
Publicado: (2020)

Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: A cross-sectional study in Chongqing, China
por: Kong, Lingxi, et al.
Publicado: (2023)

Duodenal Amyloidosis Masquerading as Iron Deficiency Anemia
por: Inayat, Faisal, et al.
Publicado: (2016)

Gastrointestinal and Hepatic Involvement in Hypereosinophilic Syndrome
por: Inayat, Faisal, et al.
Publicado: (2016)

Small Bowel Angioedema Secondary to Angiotensin-Converting Enzyme Inhibitors
por: Inayat, Faisal, et al.
Publicado: (2016)

Awareness, Knowledge, and Misperceptions Related to Nonalcoholic Fatty Liver Disease in a Community Sample of Mexican-Origin Women: A Mixed Methods Study
por: Morrill, Kristin E., et al.
Publicado: (2021)

Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma
por: Cernea, Simona, et al.
Publicado: (2023)

The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma
por: Cho, Yuri, et al.
Publicado: (2023)

Factors influencing adherence to lifestyle prescriptions among patients with nonalcoholic fatty liver disease: A qualitative study using the health action process approach framework
por: Wang, Lina, et al.
Publicado: (2023)

Salvage Plasmapheresis for Post-hepatectomy Liver Failure
por: Inayat, Faisal, et al.
Publicado: (2016)

Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2019)

Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
por: Ahn, Seon Young, et al.
Publicado: (2020)

Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma
por: Benhammou, Jihane N., et al.
Publicado: (2020)

The Gene Signature Associated with Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
por: Ge, Jiayun, et al.
Publicado: (2021)

Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
por: Costante, Federico, et al.
Publicado: (2022)

Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
por: Teng, Pai-Chi, et al.
Publicado: (2023)

Disseminative Recurrence Signature for Hepatocellular Carcinoma From Nonalcoholic Fatty Liver Disease
por: FUJIWARA, N., et al.
Publicado: (2023)

Imaging, Endoscopic and Genetic Assessment of Marfan Syndrome Presenting with Sigmoid Volvulus: A Review
por: Inayat, Faisal, et al.
Publicado: (2016)

Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: The Prognostic Role of Liver Stiffness Measurement
por: Cerrito, Lucia, et al.
Publicado: (2023)

Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
por: Behari, Jaideep, et al.
Publicado: (2023)

Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003–2018
por: Xie, Zhilan, et al.
Publicado: (2023)

Integrative Genomic Signatures Of Hepatocellular Carcinoma Derived from Nonalcoholic Fatty Liver Disease
por: Frades, Itziar, et al.
Publicado: (2015)

Nonalcoholic fatty liver disease‐related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma
por: Bertot, Luis C., et al.
Publicado: (2017)

Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes
por: Benhammou, Jihane N., et al.
Publicado: (2021)

Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges
por: Ahmad, Muhammad Imran, et al.
Publicado: (2022)

Clinico‐histological and molecular features of hepatocellular carcinoma from nonalcoholic fatty liver disease
por: Fujiwara, Naoto, et al.
Publicado: (2023)

Management of nonalcoholic fatty liver disease in the Middle East
por: Sanai, Faisal M, et al.
Publicado: (2020)

A narrative review on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis versus hepatocellular carcinoma: do you mind?
por: Toman, Daniel, et al.
Publicado: (2022)

Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Jae Seung, et al.
Publicado: (2021)

Acute Esophageal Necrosis: An Update
por: Inayat, Faisal, et al.
Publicado: (2016)

Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System
por: Kikuchi, Luciana, et al.
Publicado: (2016)

Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
por: Donati, Benedetta, et al.
Publicado: (2017)

Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma
por: Benhammou, Jihane N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_obmk94jtk8e1ufk3ae190n845p